{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910788591303321"]
[null,null,"Titolo",null,"Therapeutic advances in thrombosis [[electronic resource] /] / editors, David J. Moliterno, Steen Dalby Kristensen, Raffaele De Caterina"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, West Sussex, : Wiley-Blackwell, 2013"]
[null,null,"ISBN",null,"1-118-41089-0"]
[{"$nulls":4},"1-118-41087-4"]
[{"$nulls":4},"1-299-15803-X"]
[{"$nulls":4},"1-118-41090-4"]
[null,null,"Edizione",null,"[2nd ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (402 p.)"]
[null,null,"Disciplina",null,"616.1/35"]
[null,null,"Soggetti",null,"Thrombosis - Treatment"]
[{"$nulls":4},"Fibrinolytic agents"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Rev. ed. of: Therapeutic strategies in thrombosis / edited by Steen Dalby Kristensen, Raffaele De Caterina, and David J. Moliterno. 2006."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Arterial thrombosis : a brief overview / Lina Badimon and Valentin Fuster -- Aspirin / Carlo Patrono -- Platelet ADP P2Y12 inhibitors - thienopyridines / Joseph D. Foley III and David J. Moliterno -- Platelet ADP P2Y12 Inhibitors - non-thienopyridines / Joseph D. Foley III and David J. Moliterno -- Cilostazol and dipyridamole- more than weak inhibition of platelets / W.G. Eisert -- The inter-relationship of thrombin and platelets - the protease activated receptor-1 (PAR-1) / Matthew E. Wiisanen and David J. Moliterno -- Glycoprotein IIb/IIIa inhibitors / Marco Valgimigli and Elisa Cangiano -- Unfractionated heparin and low-molecular-weight heparin in ischemic heart disease / Marc Cohen, Omar Hassan, and Zafar Iqbal -- Pentasaccharide derivatives / Antonio Gutierrez, Pierluigi Tricoci, and John H.P. Alexander -- Intravenous direct thrombin inhibitors / A. Michael Lincoff -- Vitamin K antagonists / Freek W.A. Verheugt -- Oral direct thrombin inhibitors and oral Xa inhibitors / Steen Husted and Lars Wallentin -- Thrombolytic therapy and concomitant antithrombotic therapies / Peter R. Sinnaeve and Frans J. Van de Werf -- Antithrombotic therapy in STEMI / Kurt Huber, Raffaele De Caterina, Steen Kristensen -- Antithrombotic therapy in non-ST elevation acute coronary syndromes / Georgios J. Vlachojannis ... [et al.] -- Antithrombotic strategies in patients undergoing elective PCI / Sunil V. "]
[{"$nulls":4},"Rao and E. Magnus Ohman -- Antithrombotic management in patients with prosthetic valves / Eric G. Butchart and Raffaele De Caterina -- Stroke - thrombolysis and antithrombotic therapy / L. Creed Pettigrew and Michael R. Dobbs -- Atrial fibrillation : current and forthcoming antithrombotic therapies / Raffaele De Caterina and Giulia Renda -- Venous thromboembolism : pathophysiology, diagnosis and prophylaxis / M.P. Donadini, W. Ageno, A.G.G. Turpie -- Antithrombotic therapy in venous thrombosis and pulmonary embolism / M. Di Nisio and H.R. Büller -- Prevention and treatment of venous and arterial thrombosis in patients with specific conditions : diabetes, hypercoagulable states, pregnancy and renal insufficiency / Michel Meyer Samama, Jacqueline Conard and Grigoris Gerotziafas -- Genetics of the response to antithrombotic drugs and the need for monitoring / Jean-Philippe Collet, Gilles Montalescot, and Jean-Sébastien Hulot."]
[null,null,null,"Sommario/riassunto","Managing patients with thrombotic vascular disease is complex and challenging:   Ischemic vascular disease remains a complicated interplay of atherosclerosis and thrombosis-even with the evolution in our understanding of the pathobiology of thrombosis. There has been tremendous growth in therapeutic options which are quickly finding their place in daily practice, including a remarkable expansion in the number of intravenous and oral antithrombotic agents and new antiplatelet agents   Now more than ever, all cardiologists, hematologists, and specialists in vascular medicine, as well as other p"]